Insider holders · CIK 0001402328
Sunshine Biopharma Inc. · SBFM
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Steve N. SlilatyChief Executive Officer | 117,384,373 | 215,014,224 | 332,398,597 | Sep 14, 2018 · 10:08 am EDT | Form 4 |
| Camille SebaalySecretary | 117,234,373 | 129,468,927 | 246,703,300 | Sep 14, 2018 · 10:14 am EDT | Form 4 |
| Advanomics Corp10% Owner | 215,014,224 | — | 215,014,224 | Nov 7, 2016 · 12:10 pm EST | Form 4 |
| Abderrazzak MerzoukiChief Operating Officer | 118,467,000 | — | 118,467,000 | Sep 14, 2018 · 10:23 am EDT | Form 4 |
| David NatanDirector | 68,300 | — | 68,300 | Aug 11, 2026 · 4:23 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.